Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The pros and cons of today’s technologies for SPPS, native chemical ligation, CEPS, KAHA and recombinant technologies.
Released By Bachem
August 16, 2023
Which of the current available production techniques should be chosen for long, complex and functionalized peptides or even small proteins? Which technologies allow functionalization of peptides? Get answers to these questions by joining our next webinar where experts are discussing the pros and cons of today’s technologies for SPPS, native chemical ligation, CEPS, KAHA and recombinant technologies. Submit your questions to our experts prior to the webinar via email (webinar@bachem.com). Additionally, you can ask your questions either during the Q&A session of the webinar or in a discussion round afterwards (link to be provided during webinar). Speakers: Dr. Leendert Van Den Bos – CEO at EnzyTag BV Dr. Leendert van den Bos obtained his MSc- and PhD-degree in bio-organic chemistry from Leiden University. In 2007, he joined Organon BioSciences as a Scientist and worked subsequently for Schering-Plough, Merck Sharp & Dohme and Aspen Pharmacare mostly in the field of Process Research & Development. In 2018 he co-founded EnzyTag focusing on the development of chemo-enzymatic processes for complex peptide API’s. Leendert holds an Executive MBA from Nyenrode University. Naoki Yamamoto – Head of Business Development, Asia Pacific Naoki Yamamoto has been Head of Business Development & Sales, Asia Pacific at Bachem Japan since Jan 2022. For the past 16 years, he’s been involved in the development of new synthetic methodologies for glycopeptides and glycoproteins, purification & analytical technologies for those materials, and coordinating several collaborations and alliances with not only domestic pharma companies but also international pharms. Prior to joining Bachem Japan, he was RAQA & BD Director at 3-D Matrix (2017-2021), and a regional president at Brand Institute (2015-2016). Prior to Brand Institute, he served as a Senior Investigator at GlyTech (2012-2014) and American Peptide Company, Sunnyvale, California in the US (2009-2012). Prior to American Peptide Company, he was a Researcher at Otsuka Chemical Company (2006-2009). He received his Ph.D. degree in Chemistry from Yokohama City University, Japan in 2006.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !